Evidence map›Paper›PMID 38103644›Full record

ArticleThe Journal of biological chemistry2024

Identification of a buried β-strand as a novel disease-related motif in the human polysialyltransferases.

Rina Hatanaka, Masaya Hane, Kaito Hayakawa, Sayo Morishita, Shiho Ohno, Yoshiki Yamaguchi, Di Wu, Ken Kitajima, Chihiro Sato

Open access · goldAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Prediction of Novel Disease-Related Regions in SIGLEC-7 byInternational journal of molecular sciences · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Rina HatanakaIntegrated Glyco-BioMedical Research Center (iGMED), Institute for Glyco-core Research (iGCORE), Nagoya University, Nagoya, Japan; Bioscience and Biotechnology Center, Nagoya University, Nagoya, Japan; Graduate School of Bioagricultural Sciences, Nagoya University, Nagoya, Japan.
Masaya HaneIntegrated Glyco-BioMedical Research Center (iGMED), Institute for Glyco-core Research (iGCORE), Nagoya University, Nagoya, Japan; Bioscience and Biotechnology Center, Nagoya University, Nagoya, Japan; Graduate School of Bioagricultural Sciences, Nagoya University, Nagoya, Japan.
Kaito HayakawaIntegrated Glyco-BioMedical Research Center (iGMED), Institute for Glyco-core Research (iGCORE), Nagoya University, Nagoya, Japan; Bioscience and Biotechnology Center, Nagoya University, Nagoya, Japan; Graduate School of Bioagricultural Sciences, Nagoya University, Nagoya, Japan.
Sayo MorishitaIntegrated Glyco-BioMedical Research Center (iGMED), Institute for Glyco-core Research (iGCORE), Nagoya University, Nagoya, Japan; Bioscience and Biotechnology Center, Nagoya University, Nagoya, Japan; Graduate School of Bioagricultural Sciences, Nagoya University, Nagoya, Japan.
Shiho OhnoDivision of Structural Biology, Institute of Molecular Biomembrane and Glycobiology, Tohoku Medical and Pharmaceutical University, Sendai, Japan.
Yoshiki YamaguchiDivision of Structural Biology, Institute of Molecular Biomembrane and Glycobiology, Tohoku Medical and Pharmaceutical University, Sendai, Japan.
Di WuIntegrated Glyco-BioMedical Research Center (iGMED), Institute for Glyco-core Research (iGCORE), Nagoya University, Nagoya, Japan; Bioscience and Biotechnology Center, Nagoya University, Nagoya, Japan; Graduate School of Bioagricultural Sciences, Nagoya University, Nagoya, Japan.
Ken KitajimaIntegrated Glyco-BioMedical Research Center (iGMED), Institute for Glyco-core Research (iGCORE), Nagoya University, Nagoya, Japan; Bioscience and Biotechnology Center, Nagoya University, Nagoya, Japan; Graduate School of Bioagricultural Sciences, Nagoya University, Nagoya, Japan.
Chihiro SatoIntegrated Glyco-BioMedical Research Center (iGMED), Institute for Glyco-core Research (iGCORE), Nagoya University, Nagoya, Japan; Bioscience and Biotechnology Center, Nagoya University, Nagoya, Japan; Graduate School of Bioagricultural Sciences, Nagoya University, Nagoya, Japan. Electronic address: chi@agr.nagoya-u.ac.jp.
Nagoya University · JPTohoku Medical and Pharmaceutical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The polysialyltransferases ST8SIA2 and ST8SIA4 and their product, polysialic acid (polySia), are known to be related to cancers and mental disorders. ST8SIA2 and ST8SIA4 have conserved amino acid (AA) sequence motifs essential for the synthesis of the polySia structures on the neural cell adhesion molecule. To search for a new motif in the polysialyltransferases, we adopted the in silico Individual Meta Random Forest program that can predict disease-related AA substitutions. The Individual Meta Random Forest program predicted a new eight-amino-acids sequence motif consisting of highly pathogenic AA residues, thus designated as the pathogenic (P) motif. A series of alanine point mutation experiments in the pathogenic motif (P motif) showed that most P motif mutants lost the polysialylation activity without changing the proper enzyme expression levels or localization in the Golgi. In addition, we evaluated the enzyme stability of the P motif mutants using newly established calculations of mutation energy, demonstrating that the subtle change of the conformational energy regulates the activity. In the AlphaFold2 model, we found that the P motif was a buried β-strand underneath the known surface motifs unique to ST8SIA2 and ST8SIA4. Taken together, the P motif is a novel buried β-strand that regulates the full activity of polysialyltransferases from the inside of the molecule.

Indexed as

MutationSialyltransferasesAmino Acid MotifsAmino Acid SubstitutionComputer SimulationGolgi ApparatusHumansNeural Cell Adhesion MoleculesPoint MutationProtein Conformation, beta-StrandProtein TransportRandom ForestSialic AcidsCMP-N-acetylneuraminate-poly-alpha-2,8-sialosyl sialyltransferaseNeural Cell Adhesion Moleculespolysialic acidSialic AcidsSialyltransferasesST8SIA4 protein, humanenergy calculationpathogenic mutationpolysialic acidpolysialyltransferasesialic acid

Identifiers

PMID38103644
PMCPMC10828065
OpenAlexW4389720681

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.